C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/70 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2692506
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
La présente invention porte sur des composés de formule (I), comprenant les tautomères, les énantiomères résolus, les diastéréomères, les solvates, les métabolites, les sels et les promédicaments pharmaceutiquement acceptables de ces composés. L'invention porte également sur des procédés d'utilisation des composés de cette invention comme inhibiteurs de la protéine kinase Akt et pour le traitement de maladies hyperprolifératives telles que le cancer.
Bencsik Josef R.
Blake James F.
Chabot Christine
Kallan Nicholas C.
Liang Jun
Array Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Genentech Inc.
LandOfFree
Pyrimidyl cyclopentanes as akt protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidyl cyclopentanes as akt protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidyl cyclopentanes as akt protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2074610